Track topics on Twitter Track topics that are important to you
One of biotech’s richest private companies, Denali Therapeutics, has set its sights on an IPO to push ahead with treatments for Alzheimer’s and other confounding brain diseases. The filing marks $100 million as its IPO target, but market conditions often shift a company’s sights in the run-up to a debut. Denali’s disclosure comes on the […]
Original Article: IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain DiseasesNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...